JDRF has a plan for creating a world without type 1 diabetes (T1D) that focuses on driving promising therapies through the R&D pipeline and into the hands of individuals with T1D. A critical step in progress along the pipeline is known as the translational research phase. The goal of translational research is to move research […]
Please join us at the Ray Allen Golf Classic and Ray of Hope Luncheon hosted by Shannon and Ray Allen and Andria and Javier Holtz. Ray and Shannon’s son Walker, 6, was diagnosed with type 1 diabetes (T1D) at 17 months old. Andrew Holtz, 19, was diagnosed just after his seventh birthday. The Allen and […]
A clinical study published in PNAS provides further proof-of-concept that beta cell encapsulation holds real promise for making islet implantation a viable therapy for people with type 1 diabetes (T1D).
The Walgreens JDRF 2013 pin-pad campaign raised a record $4.6 million for JDRF, making it our most successful corporate campaign effort! From September 1 through October 31, you can help support JDRF through the Walgreens flu shot campaign.
Stephen D. Miller, Ph.D., is the Judy Gugenheim Research Professor of Microbiology–Immunology at Northwestern University Feinberg School of Medicine. Dr. Miller has spent 32 years as a faculty member at Northwestern, where his research focuses on understanding the mechanisms underlying the pathogenesis and immunoregulation of autoimmune diseases, allergic disease, and rejection of tissue and organ […]
The line between research and advocacy is a fine one for David Wheadon, M.D. As JDRF’s newly appointed executive vice president for research and advocacy, David oversees all aspects of our efforts to accelerate the discovery, development, and delivery of life-changing therapies for type 1 diabetes (T1D). It’s a big role—one filled with extraordinary promise, […]
Welcome to our final daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we have been posting summaries of notable sessions and presentations. Below are two relevant sessions from Monday, June 24: From Mice to Men and Back in Diabetic Kidney Disease Diabetic kidney disease remains one of […]
Welcome to our daily summary of type 1 diabetes (T1D) research highlights from the ADA’s 73rd Scientific Sessions! Each night, we will be posting summaries of notable sessions and presentations. Below are two relevant sessions from Friday, June 21. Beta Cell Failure in Type 1 Diabetes – Cause or Consequences? The fact that T1D is a complicated […]
JDRF-supported research is at the forefront of the American Diabetes Association’s (ADA) 73rd Scientific Sessions this year, June 21-24 in Chicago, with 13 oral presentations, 14 poster presentations, three symposium discussions, one scientific workshop, more than a dozen meetings with research partners, and 20 JDRF staff and senior leadership in attendance to represent scientific progress […]
For women with type 1 diabetes (T1D), becoming pregnant and having a healthy pregnancy raise many questions. But planning a pregnancy or adjusting to pregnant life as a person with T1D doesn’t have to be stressful. We asked Gina Capone, JDRF’s community manager for TypeOneNation and first-time mother with T1D, to share her pregnancy story […]